Genitourinary Cancer: The Latest Advances in Diagnosis and Therapy

Dear Colleagues, 

This Special Issue, “Genitourinary Cancer: The Latest Advances in Diagnosis and Therapy”, aims to gather an article collection of scientific excellence in the field of genitourinary cancer. This includes a broad-based group of genitourinary (GU) cancers in the urinary systems of both men and women. In recent years, there have been substantial advancements in both the diagnostics and therapy of entities in this group, and, therefore, we find it of crucial interest for a broad medical audience to present clinical and basic research elucidating novel tumor biology-related data, as well as their potential and recognized clinical and therapeutic impact. I think there is an emerging area of research that needs to be highlighted.

We encourage researchers to apply original research studies and rare case studies with a review of the literature as well as focused review articles since, over the last decade and more, there has been significant progress in the understanding and management of genitourinary tumors, with the introduction of new surgical options and the introduction of new therapy approaches, which without doubt are revolutionizing the management of tumor entities in this field. Articles describing novelties in prevention, epidemiology, detection, diagnosis, and new data from diverse therapeutically applicable options as well as basic research studies are welcomed.

Dr. Sanja Štifter-Vretenar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• genitourinary cancer
• prevention
• epidemiology
• diagnosis
• diagnostic markers
• oncogenesis
• tumor biology
• pathology
• prognostic indicators
• targeted therapy
• multimodality therapy
• integrative therapy